Pertuzumab has clinical activity in advanced ovarian cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1551, 2006-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pertuzumab is active in the treatment of patients with advanced cancer

Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Gemcitabine plus docetaxel `has moderate activity' in advanced pancreatic cancer

Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Paclitaxel plus cisplatin and lonidamine showed `good activity' in advanced ovarian cancer

Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Bortezomib with or without docetaxel has modest activity for refractory or recurrent advanced non-small-cell lung cancer

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Combination treatment with gemcitabine, oxaliplatin, fluorouracil and calcium levofolinate in patients with advanced colorectal cancer has high antitumour activity

Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite